论文部分内容阅读
Resistance to antineoplastic drugs represents a major obstacle to the success of cancer chemotherapy.The mechanisms of drug resistance are polygenetic and yet to be completely defined.Successful development of effective drug resistance reversal agents is, therefore, heavily dependent on our understanding to the various target proteins and pathways involved in the emergence of drug resistance phenotype.